The qPCR instruments market is expected to grow steadily between 2025 and 2035, driven by increasing adoption of molecular ...

The U.S. Food and Drug Administration blocked a similar successful treatment for mitochondrial disease a quarter of century ...

PFAS, or forever chemicals, can wreak havoc on the body, disrupting hormones and impacting the immune system. Now, ...

As a researcher, educator and administrator with a knack for making connections, Cynthia Sides has a vision for the Arkansas ...

Lesley Cyford has a job and her husband is a doctor. They might not be able to afford their severely disabled son's care under Trump's Medicaid cuts.

New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular ...

The study finds that the organochlorine fungicide Chlorothalonil has adverse developmental and reproductive effects on ...

Sarepta Therapeutics said it will eliminate 36% of its workforce—approximately 500 jobs—in a restructuring that follows the ...

The FDA clears GL-IL2-138, a groundbreaking oral drug modulating natural IL-2, set to revolutionize treatment in oncology.

A trio of scientists at Norwich Research Park have been selected to work on two ground-breaking international research projects.

Human organs-on-chips and organoids offer new alternatives to animals for drug development, but there is still a long way to ...

Cullinan's innovative approach and Zipalertinib's potential approval in 2026 position it as a promising biotech investment.